查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1896227

基于营养基因组学的膳食补充剂市场预测至2032年：按补充剂类型、个人化方法、分销管道、最终用户和地区分類的全球分析

Nutrigenomics-Based Supplements Market Forecasts to 2032 - Global Analysis By Supplement Type, Personalization Approach, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，全球基于营养基因组学的补充剂市场预计到 2025 年将价值 18 亿美元，到 2032 年将达到 55 亿美元。

基于营养基因组学的营养补充剂是一种旨在透过利用个体基因组成资讯来优化代谢功能、营养利用率和整体健康的营养产品。它们是基于DNA分析，以了解特定基因如何影响人体对维生素、矿物质、抗氧化剂和生物活性化合物的反应。根据与发炎、解毒、代谢、营养吸收等相关的基因标记，营养补充剂会根据每个人的生物需求进行定制，而不是采用千篇一律的方法。这种个人化策略旨在透过将营养配方与每个人的独特基因谱相匹配，来改善健康、预防营养缺乏、增强健康水平并降低患病风险。

人们越来越意识到基因与饮食之间的相互作用

消费者越来越意识到遗传倾向会影响营养吸收、新陈代谢和整体健康。这种日益增长的意识推动了对根据个人基因谱量身定制的营养补充剂的需求，从而提供更精准有效的解决方案。个人化营养正受到注重健康的消费者的青睐，他们寻求的是针对性的干预措施，而非千篇一律的产品。强调基因与饮食之间联繫的营销宣传活动和科学论文进一步激发了消费者的兴趣。因此，对基因与饮食相互作用的认识正在成为市场扩张的主要驱动力。

营养基因组学声明缺乏明确的监管规定

许多保健品都宣称具有基因个人化功效，但监管机构往往缺乏标准化的框架来检验这些说法。这种模糊性给製造商带来了挑战，使他们难以在不同地区以可信且一致的方式进行产品定位。消费者对未经证实的说法持怀疑态度，减缓了产品的普及，尤其是在风险规避型人群中。检验的不不确定性也使企业因担心合规风险而不敢进行大规模商业化投资。因此，监管不明朗仍然是产品广泛市场渗透的一大障碍。

营养基因体学研究与分析技术的进展

基因定序技术的快速发展使DNA检测更加经济实惠，也更容易被消费者接受。这些进步使得精准识别与营养代谢相关的遗传标记成为可能，推动了消费者对个人化营养补充品的需求。人工智慧和巨量资料分析的融合进一步提高了建议的准确性，增强了消费者的信任。研究机构和生技公司正与营养补充品公司进行越来越多的合作，共同开发实证产品。这项科学进步与消费者对个人化和透明化健康解决方案的需求不谋而合。

临床证据不足以支持产品有效性

基因检测虽然能够帮助我们了解体质倾向，但许多营养补充品配方缺乏可靠的临床试验来证明其有效性。这种差距降低了消费者的信任度，也限制了寻求实证建议的医疗保健专业人员的采纳。长期研究的缺乏进一步限制了安全性和持续有效性的检验。提供疗效确切的传统营养补充剂的竞争对手给营养基因组学产品带来了更大的压力。如果没有更强有力的临床支持，基于营养基因组学的营养补充剂可能会被视为小众产品或实验性产品。

新冠疫情的影响

新冠疫情对营养基因组学补充剂市场产生了复杂的影响。供应链中断导致产品上市延迟，基因检测服务取得受限，减缓了多个地区的普及速度。疫情期间，经济的不确定性也降低了消费者对高端个人化补充品的支出。然而，疫情也提高了人们对免疫力、营养和预防保健的认识，重新激发了人们对个人化解决方案的兴趣。由于实体诊所面临诸多限制，提供居家DNA检测和补充剂配送服务的线上平台获得了更多关注。

预计在预测期内，维生素和矿物质细分市场将占据最大的市场份额。

在预测期内，维生素和矿物质细分市场预计将占据最大的市场份额，这主要得益于其广泛的消费群以及在营养领域的稳固​​地位。营养基因体学透过根据遗传倾向客製化补充剂，提高吸收率和功效，从而为该品类增添价值。存在营养缺乏或基因突变的消费者可从针对性维生素和矿物质配方中获益，从而推动市场需求。价格实惠以及在零售和线上通路的广泛供应进一步巩固了该细分市场的主导地位。为了在成熟的类别中脱颖而出，製造商正利用基于DNA的个人化技术进行创新。人们对基因与饮食之间相互作用的认识不断提高，也进一步增强了个人化维生素和矿物质产品的吸引力。

预计在预测期内，基于DNA的个人化客製化领域将呈现最高的复合年增长率。

在预测期内，基于DNA的个人化产品细分市场预计将实现最高成长率，因为基因检测技术的进步使得DNA分析更加便捷，并且能够提供精准的营养补充建议。尤其年轻的科技达人消费者对基于DNA的个人化产品青睐有加，因为他们重视创新和客製化。人工智慧驱动的分析技术的应用提高了准确性，并增强了消费者对个人化产品的信任。生技公司与营养品公司之间的合作加速了产品研发，也促进了该细分市场的成长。强调产品独特性和科学性的行销宣传活动正在推动其进一步普及。

比最大的地区

预计在预测期内，北美地区将占据最大的市场份额，这主要得益于消费者对个人化营养的强烈认知。该地区受益于基因检测服务的广泛应用和成熟的营养补充剂市场。美国和加拿大的消费者对以科学为导向的健康解决方案接受度很高，这巩固了该地区的主导地位。大型生物技术公司和营养基因组学Start-Ups的存在正在加速创新和商业化进程。儘管法律规范仍在不断完善，但与其他地区相比，其提供的指南相对清晰，有利于相关技术的推广应用。较高的可支配收入和对高端健康产品的投资意愿进一步增强了市场需求。

预计年复合成长率最高的地区

由于人们对预防性医疗保健的兴趣日益浓厚，预计亚太地区在预测期内将实现最高的复合年增长率。中国、印度和日本等国家年轻族群对个人化营养补充剂的需求不断增长。不断壮大的中产阶级和日益增长的可支配收入推动了高级产品的普及。政府为促进医疗保健和营养领域的创新而采取的措施进一步推动了需求。电子商务平台使基于营养基因组学的营养补充剂在各个市场更容易取得。人们对基因与饮食之间相互作用的认识不断提高，正在加速此类产品的普及，尤其是在都市区。

免费客製化服务

所有购买此报告的客户都将获得以下免费自订选项之一：

  • 公司概况
    • 最多三家新增市场参与企业进行全面分析
    • 主要参与企业（最多3家公司）的SWOT分析
  • 区域细分
    • 根据客户要求，对主要国家进行市场估算和预测，并计算复合年增长率（註：可行性需确认）。
  • 竞争基准化分析
    • 从产品系列、地域覆盖范围和策略联盟等方面对主要参与企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 摘要
  • 相关利益者
  • 调查范围
  • 调查方法
  • 研究材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球营养基因体学膳食补充品市场（依补充剂类型划分）

  • 维生素和矿物质
  • 益生菌和益生元
  • Omega-3脂肪酸和健康脂肪
  • 蛋白质和胺基酸
  • 特殊营养补充品
  • 其他的

6. 全球以营养基因体学为基础的个人化膳食补充剂市场

  • 基于DNA的个性化
  • 基于微生物组的个人化
  • 生活方式和环境数据的整合
  • 基于人工智慧/机器学习演算法的个人化
  • 其他的

7. 全球营养基因组学补充品市场（按分销管道划分）

  • 直接面向消费者 (D2C) 平台
  • 药房和药品商店
  • 专业营养品店
  • 网路市集
  • 其他的

8. 全球以营养基因体学为基础的补充剂市场（按最终用户划分）

  • 千禧世代与Z世代
  • X世代
  • 婴儿潮世代
  • 其他的

9. 全球营养基因体学补充市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：重大进展

  • 协议、伙伴关係、合作和合资企业
  • 併购
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十一章 企业概况

  • Nutrigenomix
  • DNAfit Life Sciences
  • Genova Diagnostics
  • GX Sciences
  • Metagenics
  • Thorne HealthTech
  • LifeGenomics
  • GenePlanet
  • MyDNA
  • Toolbox Genomics
  • Vitagene
  • DayTwo
  • Habit Personalized Nutrition
  • Persona Nutrition
Product Code: SMRC32915

According to Stratistics MRC, the Global Nutrigenomics-Based Supplements Market is accounted for $1.8 billion in 2025 and is expected to reach $5.5 billion by 2032 growing at a CAGR of 16.8% during the forecast period. Nutrigenomics-based supplements are nutrition products designed using insights from a person's genetic makeup to optimize metabolic functions, nutrient utilization, and overall health. They rely on DNA analysis to understand how specific genes influence responses to vitamins, minerals, antioxidants, and bioactive compounds. Based on these genetic markers-such as those related to inflammation, detoxification, metabolism, and nutrient absorption-supplements are customized to support individual biological needs rather than a one-size-fits-all approach. This personalized strategy aims to improve health outcomes, prevent deficiencies, enhance wellness, and reduce disease risks by aligning nutrient formulations with each person's unique genetic profile.

Market Dynamics:

Driver:

Growing awareness of gene-diet interaction

Consumers are increasingly recognizing that genetic predispositions influence nutrient absorption, metabolism, and overall health outcomes. This awareness is fueling demand for supplements tailored to individual genetic profiles, offering more precise and effective solutions. Personalized nutrition is gaining traction among health-conscious populations who seek targeted interventions rather than generic products. Marketing campaigns and scientific publications highlighting gene-diet links are further accelerating consumer interest. As a result, gene-diet awareness is emerging as a primary driver of market expansion.

Restraint:

Limited regulatory clarity for nutrigenomic claims

Many supplements are marketed with genetic personalization benefits, but regulatory bodies often lack standardized frameworks to validate these claims. This ambiguity creates challenges for manufacturers in positioning products credibly and consistently across regions. Consumer skepticism about unverified claims slows adoption, particularly among risk-averse populations. Regulatory uncertainty also discourages investment in large-scale commercialization, as companies fear compliance risks. Consequently, limited regulatory clarity remains a significant restraint to widespread market penetration.

Opportunity:

Advancements in nutrigenomics research and analytics

Rapid progress in genetic sequencing technologies has made DNA testing more affordable and accessible to consumers. These advancements enable precise identification of genetic markers linked to nutrient metabolism, driving demand for personalized supplements. Integration of AI and big data analytics further enhances the accuracy of recommendations, strengthening consumer trust. Research institutions and biotech firms are increasingly collaborating with supplement companies to develop evidence-based products. This scientific progress aligns with consumer demand for personalization and transparency in health solutions.

Threat:

Insufficient clinical evidence supporting product efficacy

While genetic testing provides insights into predispositions, many supplement formulations lack robust clinical trials to prove effectiveness. This gap reduces consumer confidence and limits adoption among healthcare professionals who demand evidence-based recommendations. The absence of long-term studies further restricts validation of safety and sustained benefits. Competitors offering traditional supplements with established efficacy create additional pressure on nutrigenomics products. Without stronger clinical backing, nutrigenomics supplements risk being perceived as niche or experimental.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the Nutrigenomics-Based Supplements market. Supply chain disruptions delayed product launches and restricted access to genetic testing services, slowing adoption in several regions. Economic uncertainty also reduced consumer spending on premium personalized supplements during the crisis. However, the pandemic heightened awareness of immunity, nutrition, and preventative health, driving renewed interest in personalized solutions. Online platforms offering at-home DNA testing and supplement delivery gained traction as physical clinics faced restrictions.

The vitamins & minerals segment is expected to be the largest during the forecast period

The vitamins & minerals segment is expected to account for the largest market share during the forecast period due to its broad consumer base and established role in nutrition. Nutrigenomics enhances this category by tailoring supplementation to genetic predispositions, improving absorption and efficacy. Consumers with deficiencies or genetic variations benefit from targeted vitamin and mineral formulations, reinforcing demand. The segment's dominance is further supported by its affordability and widespread availability across retail and online channels. Manufacturers are innovating with DNA-based personalization to differentiate offerings within this established category. Rising awareness of gene-diet interaction strengthens the appeal of personalized vitamins and minerals.

The DNA-based personalization segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the DNA-based personalization segment is predicted to witness the highest growth rate owing to advances in genetic testing have made DNA analysis more accessible, enabling precise supplement recommendations. Younger demographics and tech-savvy consumers are particularly drawn to DNA-based personalization, valuing innovation and customization. Integration of AI-driven analytics enhances accuracy, reinforcing consumer trust in personalized products. The segment benefits from partnerships between biotech firms and supplement companies, accelerating product development. Marketing campaigns emphasizing uniqueness and scientific credibility further boost adoption.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share driven by strong consumer awareness of personalized nutrition. The region benefits from widespread availability of genetic testing services and established supplement markets. Consumers in the United States and Canada are highly receptive to science-driven wellness solutions, reinforcing regional leadership. The presence of leading biotech firms and nutrigenomics startups accelerates innovation and commercialization. Regulatory frameworks, though evolving, provide relatively clearer guidance compared to other regions, supporting adoption. High disposable incomes and willingness to invest in premium health products further strengthen demand.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR by rising focus on preventative health. Countries such as China, India, and Japan are witnessing growing demand for personalized supplements among younger demographics. Expanding middle-class populations and increasing disposable incomes support premium product adoption. Government initiatives promoting innovation in healthcare and nutrition further boost demand. E-commerce platforms are making nutrigenomics-based supplements more accessible across diverse markets. Rising awareness of gene-diet interaction is accelerating adoption, particularly in urban centers.

Key players in the market

Some of the key players in Nutrigenomics-Based Supplements Market include Nutrigenomix, DNAfit Life Sciences, Genova Diagnostics, GX Sciences, Metagenics, Thorne HealthTech, LifeGenomics, GenePlanet, MyDNA, Toolbox Genomics, Vitagene, DayTwo, Habit Personalized Nutrition and Persona Nutrition.

Key Developments:

In August 2025, Genova Diagnostics reported operations across over 10,000 healthcare providers globally, with services spanning North America, Europe, and Asia. This expansion reflects rising demand for nutrigenomics-based supplements and personalized nutrition testing.

In March 2024, DNAfit launched expanded genetic testing panels covering nutrition, fitness, and stress, directly linked to supplement personalization. These offerings allow practitioners and consumers to tailor nutraceuticals to genetic predispositions, reinforcing DNAfit's leadership in personalized health.

Supplement Types Covered:

  • Vitamins & Minerals
  • Probiotics & Prebiotics
  • Omega-3 & Healthy Fats
  • Protein & Amino Acids
  • Specialty Nutraceutical
  • Other Supplement Types

Personalization Approachs Covered:

  • DNA-Based Personalization
  • Microbiome-Based Personalization
  • Lifestyle & Environmental Data Integration
  • AI/ML Algorithm-Driven Personalization
  • Other Personalization Approachs

Distribution Channels Covered:

  • Direct-to-Consumer (D2C) Platforms
  • Pharmacies & Drugstores
  • Specialty Nutrition Stores
  • Online Marketplaces
  • Other Distribution Channels

End Users Covered:

  • Millennials & Gen Z
  • Gen X
  • Baby Boomers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Nutrigenomics-Based Supplements Market, By Supplement Type

  • 5.1 Introduction
  • 5.2 Vitamins & Minerals
  • 5.3 Probiotics & Prebiotics
  • 5.4 Omega-3 & Healthy Fats
  • 5.5 Protein & Amino Acids
  • 5.6 Specialty Nutraceutical
  • 5.7 Other Supplement Types

6 Global Nutrigenomics-Based Supplements Market, By Personalization Approach

  • 6.1 Introduction
  • 6.2 DNA-Based Personalization
  • 6.3 Microbiome-Based Personalization
  • 6.4 Lifestyle & Environmental Data Integration
  • 6.5 AI/ML Algorithm-Driven Personalization
  • 6.6 Other Personalization Approachs

7 Global Nutrigenomics-Based Supplements Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Direct-to-Consumer (D2C) Platforms
  • 7.3 Pharmacies & Drugstores
  • 7.4 Specialty Nutrition Stores
  • 7.5 Online Marketplaces
  • 7.6 Other Distribution Channels

8 Global Nutrigenomics-Based Supplements Market, By End User

  • 8.1 Introduction
  • 8.2 Millennials & Gen Z
  • 8.3 Gen X
  • 8.4 Baby Boomers
  • 8.5 Other End Users

9 Global Nutrigenomics-Based Supplements Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Nutrigenomix
  • 11.2 DNAfit Life Sciences
  • 11.3 Genova Diagnostics
  • 11.4 GX Sciences
  • 11.5 Metagenics
  • 11.6 Thorne HealthTech
  • 11.7 LifeGenomics
  • 11.8 GenePlanet
  • 11.9 MyDNA
  • 11.10 Toolbox Genomics
  • 11.11 Vitagene
  • 11.12 DayTwo
  • 11.13 Habit Personalized Nutrition
  • 11.14 Persona Nutrition

List of Tables

  • Table 1 Global Nutrigenomics-Based Supplements Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Nutrigenomics-Based Supplements Market Outlook, By Supplement Type (2024-2032) ($MN)
  • Table 3 Global Nutrigenomics-Based Supplements Market Outlook, By Vitamins & Minerals (2024-2032) ($MN)
  • Table 4 Global Nutrigenomics-Based Supplements Market Outlook, By Probiotics & Prebiotics (2024-2032) ($MN)
  • Table 5 Global Nutrigenomics-Based Supplements Market Outlook, By Omega-3 & Healthy Fats (2024-2032) ($MN)
  • Table 6 Global Nutrigenomics-Based Supplements Market Outlook, By Protein & Amino Acids (2024-2032) ($MN)
  • Table 7 Global Nutrigenomics-Based Supplements Market Outlook, By Specialty Nutraceutical (2024-2032) ($MN)
  • Table 8 Global Nutrigenomics-Based Supplements Market Outlook, By Other Supplement Types (2024-2032) ($MN)
  • Table 9 Global Nutrigenomics-Based Supplements Market Outlook, By Personalization Approach (2024-2032) ($MN)
  • Table 10 Global Nutrigenomics-Based Supplements Market Outlook, By DNA-Based Personalization (2024-2032) ($MN)
  • Table 11 Global Nutrigenomics-Based Supplements Market Outlook, By Microbiome-Based Personalization (2024-2032) ($MN)
  • Table 12 Global Nutrigenomics-Based Supplements Market Outlook, By Lifestyle & Environmental Data Integration (2024-2032) ($MN)
  • Table 13 Global Nutrigenomics-Based Supplements Market Outlook, By AI/ML Algorithm-Driven Personalization (2024-2032) ($MN)
  • Table 14 Global Nutrigenomics-Based Supplements Market Outlook, By Other Personalization Approachs (2024-2032) ($MN)
  • Table 15 Global Nutrigenomics-Based Supplements Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 16 Global Nutrigenomics-Based Supplements Market Outlook, By Direct-to-Consumer (D2C) Platforms (2024-2032) ($MN)
  • Table 17 Global Nutrigenomics-Based Supplements Market Outlook, By Pharmacies & Drugstores (2024-2032) ($MN)
  • Table 18 Global Nutrigenomics-Based Supplements Market Outlook, By Specialty Nutrition Stores (2024-2032) ($MN)
  • Table 19 Global Nutrigenomics-Based Supplements Market Outlook, By Online Marketplaces (2024-2032) ($MN)
  • Table 20 Global Nutrigenomics-Based Supplements Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
  • Table 21 Global Nutrigenomics-Based Supplements Market Outlook, By End User (2024-2032) ($MN)
  • Table 22 Global Nutrigenomics-Based Supplements Market Outlook, By Millennials & Gen Z (2024-2032) ($MN)
  • Table 23 Global Nutrigenomics-Based Supplements Market Outlook, By Gen X (2024-2032) ($MN)
  • Table 24 Global Nutrigenomics-Based Supplements Market Outlook, By Baby Boomers (2024-2032) ($MN)
  • Table 25 Global Nutrigenomics-Based Supplements Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.